Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 263K | Aug 27, 2021 | Direct | ||
Kymera Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 0 | $30.05 | Aug 27, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYMR | Kymera Therapeutics, Inc. | Aug 27, 2021 | 3 | -$1.36M | 4 | Aug 27, 2021 | Chief Scientific Officer |
KYMR | Kymera Therapeutics, Inc. | Aug 17, 2021 | 6 | -$1.64M | 4 | Aug 19, 2021 | Chief Scientific Officer |